drugset / Trial / NCT03385369
A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese Descent
RandomizedParallel-groupTriple-blindBasic science
Summary
This is a phase I, randomized, blinded study to evaluate the safety and pharmacokinetics of MEDI0382 following single dose administration to overweight/obese subjects of Japanese or Chinese descent
Timeline
- Start
- 2018-01-05
- Primary completion
- 2018-04-12
- Completion
- 2018-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cotadutide | Peptide | 50 ug | Subcutaneous |
| Subject | Cotadutide | Peptide | 100 ug | Subcutaneous |
| Subject | Cotadutide | Peptide | 150 ug | Subcutaneous |
Indications
No indication recorded.